Methyl (2E)-3-{3-fluoro-2-[(triphenylphosphoranylidene)amino]phenyl}propenoate → Methyl [8-fluoro-3-(2-methoxy-5-trifluoromethylphenyl)-2-(9-methyl-3,4-dihydro-1H-pyrazino[1,2-a]indol-2-yl)-3,4-dihydroquinazolin-4-yl]acetate

HRID 1798722Notes

Reaction equation

HRID 1798722 reaction equation
[F:1][C:2]1[C:3]([N:14]=P(C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=[C:4](/[CH:8]=[CH:9]/[C:10]([O:12][CH3:13])=[O:11])[CH:5]=[CH:6][CH:7]=1.[N:34]([C:37]1[CH:42]=[C:41]([C:43]([F:46])([F:45])[F:44])[CH:40]=[CH:39][C:38]=1[O:47][CH3:48])=[C:35]=O.[CH3:49][C:50]1[C:51]2[CH:52]=[C:53]3[CH2:62][NH:61][CH2:60][CH2:59][N:54]3[C:55]=2[CH:56]=[CH:57][CH:58]=1>>[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[C:4]2[C:3]=1[N:14]=[C:35]([N:61]1[CH2:60][CH2:59][N:54]3[C:55]4[CH:56]=[CH:57][CH:58]=[C:50]([CH3:49])[C:51]=4[CH:52]=[C:53]3[CH2:62]1)[N:34]([C:37]1[CH:42]=[C:41]([C:43]([F:46])([F:45])[F:44])[CH:40]=[CH:39][C:38]=1[O:47][CH3:48])[CH:8]2[CH2:9][C:10]([O:12][CH3:13])=[O:11]

Participants

4

Reactant 3

HCID 11983908Methyl (2E)-3-{3-fluoro-2-[(triphenylphosphoranylidene)amino]phenyl}propenoateHCID 11983909Benzene, 2-isocyanato-1-methoxy-4-(trifluoromethyl)-HCID 119839109-Methyl-1,2,3,4-tetrahydropyrazino[1,2-a]indole

Product 1

HCID 11983911Methyl [8-fluoro-3-(2-methoxy-5-trifluoromethylphenyl)-2-(9-methyl-3,4-dihydro-1H-pyrazino[1,2-a]indol-2-yl)-3,4-dihydroquinazolin-4-yl]acetate

Procedure

Starting with 563 mg (1.2 mmol) of the iminophosphorane from Example 12A, 268 mg (1.2 mmol) of 2-isocyanato-1-methoxy-4-(trifluoromethyl)benzene and 230 mg (1.2 mmol) of 9-methyl-1,2,3,4-tetrahydropyrazino[1,2-a]indole from Example 31A, the general procedure [M] gives 325 mg (42% of theory) of product.

Workup

  1. customthe general procedure [M] gives 325 mg (42% of theory) of product

Sources & evidence

ORD record
ord-7ed90885a7c24807908175e78ee5a4e9
Source dataset
uspto-grants-2013_01
Patent number
US08343981B2

Reaction notes

Loading…